1 t bloody stools with fever, prostration, and abdominal cramps.

2 es, which include bloody diarrhea and severe abdominal cramps.

3 ents reported nausea (95%), dizziness (72%), abdominal cramps (58%), headache (52%), vomiting (51%),

4           Patients reported diarrhea (100%), abdominal cramps (93%), fever (93%), bloody stools (72%)

5                      One patient experienced abdominal cramps and diarrhea necessitating interruption

6 stinal symptoms, including emesis, diarrhea, abdominal cramping, and gastrointestinal bleeding.

7 itis was admitted to the hospital because of abdominal cramping, diarrhea, hematochezia, fever to a p

8 , menstrual disturbances, breast tenderness, abdominal cramping, dizziness, headache, and mood change

9 ts on arm 1 had significantly (P < .05) more abdominal cramps, fatigue, transient hearing loss, febri

10 s were observed except for mild diarrhea and abdominal cramping in the infusion group on the infusion

11 iting toxicity was grade 3/4 diarrhea and/or abdominal cramps in six of 12 patients treated at 24 mg/

12        The most common side effect was lower abdominal cramping/pain (P = .01).

13 For specific GI symptoms (eg, gas, diarrhea, abdominal cramping), there were no significant differenc

14                         Grade 0, 1, 2, and 3 abdominal cramps were observed in 32%, 45%, 21%, and 2%

15 d measure of diarrhea, nausea, vomiting, and abdominal cramps, were recorded.